Zifogaptide

N/A

Report date: 2025/05/23 12:02:08
NME

Base Information

Drug NameZifogaptide
Drug Alias Namealpha-Connexin carboxyl-Terminal 1 peptideaCT1 ophthalmic solutioniNexinGranexinGranexin® Gel +[7] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGap junction alpha-1 protein agonists
TargetsGap junction alpha-1 protein
Therapy Area/IndicationsRadiation InjuriesBurnsWounds and Injuries +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[6] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedical University Of South CarolinaFirststring Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesXequel Bio Inc
Inactive CompaniesMedical University Of South Carolina
Active IndicationsRadiation InjuriesCicatrixRadiodermatitis
Inactive IndicationsBurnsWounds and InjuriesVaricose Ulcer +[4] 

Other Information

ATC CodeN/A
Related LinksN/A